メディカルエステティック市場 – 2030年までの世界予測

Report Overview

“The global medical aesthetics market is estimated to reach USD 35.32 Billion by 2030 from USD 17.16 million in 2024, at a CAGR of 12.8% during the forecast period).”

世界の医療美容市場は、2024年の1,716万米ドルから2030年までに353億2,000万米ドルに達すると推定されており、予測期間中のCAGRは12.8%です。

The growth of the market of medical aesthetics is very high due to several factors. First, from the demand side, minimally invasive and non-invasive treatments are increasingly demanded since they have several advantages over conventional methods, such as a decreased risk of side effects and minimum recovery periods. Advances in aesthetic technologies, including multifunctional lasers and various skin rejuvenation techniques, enhance the effectiveness and precision of these treatments with better results that would benefit more people and make them more accessible and appealing to a larger market. The market for aesthetic procedures has been eased by increased disposable incomes in the developing world. Growing emphasis on wellness, self-care, and social media has increased demand as people seek beauty treatments to stay youthful. Other drivers include an aging population in developed countries looking for anti-aging solutions to a variety of problems. These factors are all contributing to the rise in the medical aesthetics market.

“The facial aesthetic products segment held the largest share of the market in 2023.”

The market for medical aesthetics captured the largest share of facial aesthetic products in 2023. This segment deals with facial aesthetic products, cosmetic implants, skin aesthetic devices, body contouring devices, physician-dispensed cosmeceuticals, skin lighteners, thread lift products, hair removal devices, tattoo removal devices, physician-dispensed eyelash products, and nail treatment laser devices. The major portion of facial aesthetic products accounts for non-invasive treatments for facial rejuvenation, such as Botox and dermal fillers. These products are preferred more because of their ability to deliver effective results with minimal downtime in a natural appearance. The market will also experience further growth because of the rising demand for aesthetic procedures that can be done at home. This shift toward at-home treatments, enabled by the availability of advanced, user-friendly devices, is contributing to the growing accessibility and affordability of facial aesthetic solutions. As a result, the facial aesthetic products segment shall remain on track to advance at the highest rate, following consumer preference for convenient and effective aesthetic enhancements.

“The lipolysis segment is projected to register the highest CAGR of the non-surgical procedures by procedure during the forecast period.”

The medical aesthetics market is segmented into surgical and nonsurgical procedures. Surgical procedures account for areas of breast augmentation, rhinoplasty, facelifts, body lifts, etc, while non-surgical procedures include anti-aging and skin rejuvenation, tattoo and scar removal, hair removal, lipolysis, and many others. Among these, the lipolysis segment is anticipated to record the highest compound annual growth rate (CAGR) within the non-surgical procedures market from 2024 to 2030. Lipolysis is a non-invasive technique for reducing excess fat that is gaining immense popularity due to its ability to target particular fat deposits without surgery. Consumer spending on cosmetic treatments, especially those that will help achieve body contouring, leads to the rapid growth of this segment. This is because numerous people are opting for more affordable and effective alternatives to traditional surgery. With lipolysis now available in the market, the development of advanced devices that allow for the precise extraction of fats with minimal downtime is further enhancing the demand. An increase in body consciousness with an increased awareness of non-surgical fat-reduction options contributes to the growth of the segment. The lipolysis segment is expected to experience continued growth and remain a key player in the medical aesthetics market across the forecast period as consumers remain focused on swift, efficient, and minimally invasive treatment options

“The market in the Asia Pacific region is expected to witness the highest growth during the forecast period.”

The Asia Pacific (APAC) region is anticipated to be the fastest-growing medical aesthetics market over the forecast period, mainly due to the rapid development of healthcare infrastructure, more so in emerging economies such as India and China. Moreover, investment in the respective healthcare sectors of these countries fosters the demand for advanced medical aesthetic systems, including dermatology, body contouring, and facial aesthetics. Additionally, increasing disposable incomes and the fast-expanding middle class in the region are further fueling demand for aesthetic treatments since it’s a move toward skin rejuvenation, anti-aging, and cosmetic procedures.

The industry has seen the APAC region become a more significant area of interest for companies involved in medical aesthetics, where there has been an increasing focus on innovative products offered to consumers’ changing preferences. Increased clinic, hospital, and medical spa coverage in the region is the accelerator for the adoption of these technologies. Increased awareness and acceptance of aesthetic treatments are expected to fuel the growth of the market soon. The APAC region is very poised to lead the medical aesthetics market with the rising healthcare infrastructure and has numerous opportunities for growth and expansion in the sector.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1–35%, Tier 2–45%, and Tier 3–20%
• By Designation: Director-level–25%, C-level–35%, and Others–40%
• By Region: North America–40%, Europe–30%, Asia Pacific–20%, Latin America-5%, Middle East and Africa-5%

The prominent players in the medical aesthetics market are AbbVie Inc. (US), Bausch Health Companies Inc. (Canada & Johnson (US), and others.

Research Coverage

This market is segmented by product, application, end-user, and region. The report discusses drivers, restraints, opportunities, and challenges affecting the medical aesthetic market. It provides the prospects of opportunities and challenges for the stakeholders, along with detailing the competitive landscape of leading players. The micro-markets are further segmented focusing on growth trends, prospects, and the contributions of these trends towards the medical aesthetic market. To this, revenue generation through different market segments shall be forecasted and their respective growth focus put together based on five major geographies.

Key Benefits of Buying this Report

This report is to be profited by new and existing players. It will provide deep information about the medical aesthetic market for them to understand any investment opportunities. The present report provides complete information on the key players and minor players. Hence, this supports effective risk analysis along with informed decisions about investment. Due to the accurate segmentation based on end-users and geographies, this report gives niche-level views of the selected market areas.

Through this report, readers get insightful views into the following parameters:

• Analysis of the key growth drivers, restraints, challenges, and opportunities influencing market growth for the medical aesthetic market. The major driving force behind the medical aesthetic market is an increase in the geriatric population. Another reason driving the growth of the market is the increasing need for accurate, and minimally invasive solutions. With customers becoming highly attuned to non-invasive alternatives, demand for modern and efficient aesthetic solutions, including multifunctional lasers and skin rejuvenation technologies, has seen a significant increase.

• Product Development/Innovation: Advanced technologies, R&D activities, and product launches in the medical aesthetics market.

• Market Development: This report will further present the regional expansion of the medical aesthetics market, focusing on the various emerging market opportunities worldwide.

• Market Diversification: The market is increasingly diversifying due to the development of innovative products, previously untapped markets, and new trends; in addition, because of significant investments in the medical aesthetics industry, contribute to its growth as well as the constant change.

• Competitive Analysis: Exhaustive study of market share, and service offering leading strategies of major players such as AbbVie Inc (US), Alma Lasers (Israel), Cynosure (US), and GALDERMA (Switzerland), among others.

Table of Contents

1               INTRODUCTION              32

1.1           STUDY OBJECTIVES       32

1.2           MARKET DEFINITION   32

1.3           STUDY SCOPE   33

1.3.1        MARKETS COVERED AND REGIONAL SCOPE      33

1.3.2        INCLUSIONS AND EXCLUSIONS 34

1.3.3        YEARS CONSIDERED      35

1.4           CURRENCY CONSIDERED            35

1.5           STAKEHOLDERS               36

1.6           SUMMARY OF CHANGES               36

2               RESEARCH METHODOLOGY       37

2.1           RESEARCH DATA              37

2.1.1        SECONDARY DATA          38

2.1.1.1    Indicative list of secondary sources   39

2.1.1.2    Key data from secondary sources       40

2.1.2        PRIMARY DATA 40

2.1.2.1    Primary sources    41

2.1.2.2    Key data from primary sources           41

2.1.2.3    Key industry insights           42

2.1.2.4    Breakdown of primary interviews      42

2.2           MARKET SIZE ESTIMATION METHODOLOGY     44

2.2.1        VENDOR REVENUE-BASED MARKET ESTIMATION                 45

2.2.2        END-USER-BASED MARKET SIZE ESTIMATION   46

2.3           MARKET FORECASTING MODEL               46

2.4           DATA TRIANGULATION AND MARKET BREAKDOWN                 48

2.5           RESEARCH ASSUMPTIONS           49

2.6           RESEARCH LIMITATIONS             49

2.7           RISK ASSESSMENT           50

3               EXECUTIVE SUMMARY  51

4               PREMIUM INSIGHTS       55

4.1           MEDICAL AESTHETICS MARKET OVERVIEW       55

4.2           MEDICAL AESTHETICS MARKET, BY PRODUCT 56

4.3           ASIA PACIFIC: MEDICAL AESTHETICS MARKET, BY END USER, 2023 (USD MILLION)          57

4.4           REGIONAL SNAPSHOT OF MEDICAL AESTHETICS MARKET               58

5               MARKET OVERVIEW       59

5.1           INTRODUCTION              59

5.2           MARKET DYNAMICS       59

5.2.1        DRIVERS               60

5.2.1.1    Increasing adoption of minimally invasive and non-invasive

aesthetic procedures             60

5.2.1.2    Growing demand for aesthetic treatments among elderly and men                 61

5.2.1.3    Rising influence of social media         62

5.2.2        RESTRAINTS      62

5.2.2.1    Risk of infection and safety concerns                 62

5.2.2.2    Complex regulatory framework and compliance standards                 62

5.2.3        OPPORTUNITIES              63

5.2.3.1    Significant opportunities in emerging economies           63

5.2.3.2    Launch of new technologies and products       64

5.2.4        CHALLENGES    64

5.2.4.1    High cost of treatments and devices 64

5.2.4.2    Social and cultural barriers 65

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS            66

5.4           PRICING ANALYSIS          66

5.4.1        AVERAGE SELLING PRICE, BY PRODUCT (ENERGY-BASED DEVICES), 2023   67

5.4.2        AVERAGE SELLING PRICE OF INJECTABLES, BY TYPE, 2021–2023              68

5.4.3        AVERAGE SELLING PRICE OF ENERGY-BASED DEVICES, BY KEY PLAYER, 2023      69

5.4.4        AVERAGE SELLING PRICE TREND OF ENERGY-BASED DEVICES,

BY REGION, 2021–2023    70

5.5           VALUE CHAIN ANALYSIS               72

5.5.1        R&D       72

5.5.2        RAW MATERIAL PROCUREMENT & PRODUCT DEVELOPMENT                73

5.5.3        MARKETING, SALES, AND DISTRIBUTION            73

5.5.4        AFTERMARKET SERVICES             73

5.6           SUPPLY CHAIN ANALYSIS             73

5.6.1        PROMINENT COMPANIES            74

5.6.2        SMALL AND MEDIUM-SIZED ENTERPRISES          74

5.6.3        END USERS         74

5.7           ECOSYSTEM ANALYSIS  75

5.8           INVESTMENT AND FUNDING SCENARIO               77

5.9           TECHNOLOGY ANALYSIS             78

5.9.1        KEY TECHNOLOGIES     78

5.9.1.1    Laser and light-based technologies   78

5.9.1.2    Radiofrequency technology 79

5.9.1.3    Ultrasound technology         80

5.9.2        COMPLEMENTARY TECHNOLOGIES       81

5.9.2.1    AI-powered skin analysis systems      81

5.9.3        ADJACENT TECHNOLOGIES       81

5.9.3.1    Regenerative medicine and stem cell therapy  81

5.10         PATENT ANALYSIS          82

5.11         TRADE ANALYSIS             83

5.11.1      IMPORT DATA  83

5.11.1.1  Import scenario for HS code 854370 83

5.11.1.2  Import scenario for HS code 901320 84

5.11.2      EXPORT DATA  85

5.11.2.1  Export scenario for HS code 854370 85

5.11.2.2  Export scenario for HS code 901320 86

5.12         KEY CONFERENCES AND EVENTS, 2025–2026        87

5.13         CASE STUDY ANALYSIS 88

5.13.1      COMMERCIAL PARTNERSHIPS FOR MEDICAL AESTHETIC PRODUCT SALES     88

5.13.2      DIVISION OF BUSINESS TO MEET CUSTOMER DEMANDS                 88

5.13.3      COLLABORATIONS WITH SMES FOR STREAMLINING LASER-BASED DEVICES 88

5.14         REGULATORY LANDSCAPE         89

5.14.1      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             89

5.14.2      KEY REGULATORY GUIDELINES               91

5.14.2.1  North America      91

5.14.2.1.1                US           91

5.14.2.1.2                Canada   92

5.14.2.2  Europe   92

5.14.2.2.1                UK          92

5.14.2.2.2                France    93

5.14.2.2.3                Germany                 93

5.14.2.3  Asia Pacific            94

5.14.2.3.1                China      94

5.14.2.3.2                Japan      94

5.14.2.3.3                India       95

5.14.2.4  Latin America       95

5.14.2.4.1                Brazil      95

5.14.2.5  Middle East & Africa            96

5.14.2.5.1                UAE        96

5.14.3      REGULATORY APPROVALS          96

5.15         PORTER’S FIVE FORCE ANALYSIS              97

5.15.1      THREAT OF NEW ENTRANTS      98

5.15.2      THREAT OF SUBSTITUTES          98

5.15.3      BARGAINING POWER OF SUPPLIERS       98

5.15.4      BARGAINING POWER OF BUYERS             98

5.15.5      INTENSITY OF COMPETITIVE RIVALRY 98

5.16         KEY STAKEHOLDERS AND BUYING CRITERIA     99

5.16.1      KEY STAKEHOLDERS IN BUYING PROCESS           99

5.16.2      BUYING CRITERIA           100

5.17         UNMET NEEDS 100

5.18         IMPACT OF AI/GEN AI ON MEDICAL AESTHETICS MARKET               101

5.18.1      INTRODUCTION              101

5.18.2      MARKET POTENTIAL OF AI IN MEDICAL AESTHETIC APPLICATIONS 101

5.18.3      AI USE CASES     101

5.18.4      KEY COMPANIES IMPLEMENTING AI      102

5.18.5      FUTURE OF AI/GEN AI IN MEDICAL AESTHETICS ECOSYSTEM       102

6               MEDICAL AESTHETICS MARKET, BY PRODUCT 103

6.1           INTRODUCTION              104

6.2           FACIAL AESTHETIC PRODUCTS                 105

6.2.1        BOTULINUM TOXIN       106

6.2.1.1    Growing willingness for Botox process to boost market 106

6.2.2        DERMAL FILLERS             107

6.2.2.1    Natural dermal fillers           108

6.2.2.1.1 Rising use of dermal fillers in facial contouring to support growth                 108

6.2.2.2    Synthetic dermal fillers        109

6.2.2.2.1 Need for quick aesthetic enhancements to accelerate growth                 109

6.2.3        CHEMICAL PEELS            110

6.2.3.1    Increasing availability of wide range of chemical peels to expedite growth    110

6.2.4        MICRODERMABRASION                112

6.2.4.1    Growing use of low-risk and cost-effective resurfacing methods to fuel market        112

6.3           BODY CONTOURING DEVICES  113

6.3.1        NON-SURGICAL FAT REDUCTION DEVICES         115

6.3.1.1    Rise in obesity cases to sustain growth              115

6.3.2        CELLULITE REDUCTION DEVICES           116

6.3.2.1    Increasing focus on appearances to fuel market               116

6.3.3        LIPOSUCTION DEVICES                117

6.3.3.1    Growing awareness about obesity-related health risks to propel market    117

6.4           COSMETIC IMPLANTS   118

6.4.1        BREAST IMPLANTS          119

6.4.1.1    Silicone breast implants      121

6.4.1.1.1 Increasing number of promotional efforts and new products by leading companies to aid growth        121

6.4.1.2    Saline breast implants          122

6.4.1.2.1 Reduced cost of breast implants to support growth        122

6.4.2        FACIAL IMPLANTS           124

6.4.2.1    Growing awareness about benefits of facial implants over other contouring products to drive market 124

6.4.3        OTHER IMPLANTS           124

6.5           PHYSICIAN-DISPENSED COSMECEUTICALS AND SKIN LIGHTENERS     125

6.5.1        ONGOING SHIFT TOWARD DEVELOPING SAFER SKIN-LIGHTENING PRODUCTS TO FAVOR GROWTH 125

6.6           SKIN AESTHETIC DEVICES           126

6.6.1        LASER SKIN RESURFACING DEVICES       127

6.6.1.1    Booming geriatric population to support growth             127

6.6.2        NON-SURGICAL SKIN TIGHTENING DEVICES     129

6.6.2.1    Rising popularity of non-invasive methods to speed up growth                 129

6.6.3        MICRONEEDLING PRODUCTS   130

6.6.3.1    Reduced discomfort and enhanced skin rejuvenation to augment growth    130

6.6.4        LIGHT THERAPY DEVICES           131

6.6.4.1    Growing use of light therapy for pain management and sleep regulation to boost market  131

6.7           PHYSICIAN-DISPENSED EYELASH PRODUCTS    132

6.7.1        EXPANDING MIDDLE CLASS POPULATION TO ENCOURAGE GROWTH 132

6.8           HAIR REMOVAL DEVICES             133

6.8.1        LASER HAIR REMOVAL DEVICES               135

6.8.1.1    Increasing availability of user-friendly home-use laser devices

to spur growth       135

6.8.2        IPL HAIR REMOVAL DEVICES     136

6.8.2.1    Growing interest in cosmetic treatments to fuel market                 136

6.9           TATTOO REMOVAL DEVICES     137

6.9.1        NEED FOR MINIMIZED SKIN DAMAGE TO FAVOR GROWTH             137

6.10         THREAD LIFT PRODUCTS            138

6.10.1      RISING PREFERENCE FOR MINIMAL RECOVERY TIME AND QUICK RESULTS TO STIMULATE GROWTH                138

6.11         NAIL TREATMENT LASER DEVICES          139

6.11.1      INCREASING DEMAND FOR QUICK AND PAINLESS PROCEDURE TO PROMOTE GROWTH    139

6.12         HOME CARE DEVICES    140

6.12.1      GROWING DEMAND FOR AFFORDABLE AND CONVENIENT HOME-BASED TREATMENTS TO DRIVE MARKET                 140

7               MEDICAL AESTHETICS MARKET, BY TYPE OF DEVICE                 141

7.1           INTRODUCTION              142

7.2           STANDALONE DEVICES                143

7.2.1        INCREASING INNOVATIONS IN ENERGY-BASED TECHNOLOGIES TO DRIVE MARKET      143

7.3           MULTIMODAL DEVICES                144

7.3.1        GROWING AVAILABILITY OF PERSONALIZED CARE AND TAILORED TREATMENT TO PROPEL MARKET   144

7.4           AT-HOME/SELF-USE DEVICES   145

7.4.1        RISING FOCUS ON ENHANCED SKIN HEALTH TO FACILITATE GROWTH   145

8               MEDICAL AESTHETICS MARKET, BY PROCEDURE                 146

8.1           INTRODUCTION              147

8.2           NON-SURGICAL PROCEDURES  147

8.2.1        ANTI-AGING AND SKIN REJUVENATION                148

8.2.1.1    Rising preference for maintaining youthful appearance to promote growth    148

8.2.2        TATTOO REMOVAL        149

8.2.2.1    Increased accessibility to tattoo removal processes to facilitate growth    149

8.2.3        HAIR REMOVAL                 150

8.2.3.1    Growing adherence to conventional beauty standards to drive market    150

8.2.4        LIPOSUCTION   151

8.2.4.1    Increased dominance of sedentary lifestyles to encourage growth                 151

8.2.5        OTHER NON-SURGICAL PROCEDURES  152

8.3           SURGICAL PROCEDURES              153

8.3.1        BREAST IMPLANTS          154

8.3.1.1    Changing aesthetic preferences to drive market              154

8.3.2        FACELIFT & BODY LIFT PROCEDURES   155

8.3.2.1    Increasing need to reduce visible signs of aging to expedite growth    155

8.3.3        OTHER SURGICAL PROCEDURES              156

9               MEDICAL AESTHETICS MARKET, BY END USER 157

9.1           INTRODUCTION              158

9.2           CLINICS, HOSPITALS, AND MEDICAL SPAS           158

9.2.1        RISING TREND OF MEDICAL TOURISM AND PLASTIC SURGERY

TO ENCOURAGE GROWTH          158

9.3           BEAUTY CENTERS           160

9.3.1        GROWING INCLINATION TOWARD CUSTOMIZED TREATMENT TO BOOST MARKET            160

9.4           HOME CARE SETTINGS 161

9.4.1        INCREASING FOCUS ON CONVENIENCE, TREATMENT FLEXIBILITY,

AND COST SAVING TO SPUR GROWTH  161

10            MEDICAL AESTHETICS MARKET, BY REGION      162

10.1         INTRODUCTION              163

10.2         NORTH AMERICA             163

10.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 165

10.2.2      US           171

10.2.2.1  Growing adoption of advanced treatment procedures to drive market    171

10.2.3      CANADA               176

10.2.3.1  Increasing preference among aging individuals for physical rejuvenation to aid growth  176

10.3         EUROPE               180

10.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      180

10.3.2      GERMANY           187

10.3.2.1  Rising social acceptance of medical aesthetic procedures

to stimulate growth               187

10.3.3      UK          191

10.3.3.1  Booming cosmetics and beauty industry to accelerate growth                 191

10.3.4      FRANCE                195

10.3.4.1  Growing social acceptance of medical aesthetic treatments to fuel market    195

10.3.5      ITALY    199

10.3.5.1  Growing adoption of surgical procedures among young females

to boost market     199

10.3.6      SPAIN    203

10.3.6.1  Increasing availability of safe and minimally invasive treatments

to augment growth                203

10.3.7      REST OF EUROPE             206

10.4         ASIA PACIFIC     211

10.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 213

10.4.2      JAPAN   220

10.4.2.1  Rising awareness for body contouring treatments to sustain growth    220

10.4.3      CHINA  224

10.4.3.1  Increased availability of cosmetic surgery apps and online services to aid growth         224

10.4.4      INDIA    227

10.4.4.1  Increasing disposable incomes to contribute to market growth                 227

10.4.5      AUSTRALIA         231

10.4.5.1  Favorable government initiatives to promote growth     231

10.4.6      SOUTH KOREA  234

10.4.6.1  Booming medical tourism to speed up growth 234

10.4.7      REST OF ASIA PACIFIC   238

10.5         LATIN AMERICA                243

10.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 243

10.5.2      BRAZIL 250

10.5.2.1  Expanding target population base to expedite growth    250

10.5.3      MEXICO                254

10.5.3.1  Increasing inflow of medical tourists to favor growth     254

10.5.4      REST OF LATIN AMERICA             258

10.6         MIDDLE EAST & AFRICA                263

10.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 264

10.6.2      GCC COUNTRIES              270

10.6.2.1  Favorable government policies to propel market.            270

10.6.3      REST OF MIDDLE EAST & AFRICA             273

11            COMPETITIVE LANDSCAPE         278

11.1         OVERVIEW          278

11.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            278

11.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL

AESTHETICS MARKET    279

11.3         REVENUE ANALYSIS, 2020–2023  280

11.4         MARKET SHARE ANALYSIS, 2023                 281

11.4.1      ENERGY-BASED AESTHETIC DEVICES MARKET 281

11.4.2      FACIAL AESTHETIC PRODUCTS MARKET              282

11.4.3      COSMETIC IMPLANTS MARKET 282

11.5         RANKING OF KEY MARKET PLAYERS       283

11.6         COMPANY EVALUATION MATRIX, 2023  284

11.6.1      ENERGY-BASED AESTHETIC DEVICES MARKET 284

11.6.1.1  Stars        284

11.6.1.2  Emerging leaders 284

11.6.1.3  Pervasive players  284

11.6.1.4  Participants           284

11.6.2      FACIAL AESTHETIC PRODUCTS MARKET              285

11.6.2.1  Stars        285

11.6.2.2  Emerging leaders 285

11.6.2.3  Pervasive players  286

11.6.2.4  Participants           286

11.6.3      COSMETIC IMPLANTS MARKET 287

11.6.3.1  Stars        287

11.6.3.2  Emerging leaders 287

11.6.3.3  Pervasive players  287

11.6.3.4  Participants           287

11.6.4      COMPANY FOOTPRINT: KEY PLAYERS, 2023         289

11.6.4.1  Company footprint               289

11.6.4.2  Region footprint   290

11.6.4.3  Product footprint  291

11.6.4.4  Type of device footprint      292

11.6.4.5  Procedure footprint              293

11.6.4.6  End-user footprint                294

11.6.5      COMPANY BENCHMARKING: STARTUPS/SMES, 2023                 295

11.6.5.1  Detailed list of key startups/SMEs    295

11.6.5.2  Competitive benchmarking of startups/SMEs 296

11.7         COMPANY VALUATION AND FINANCIAL METRICS                 297

11.8         BRAND/PRODUCT COMPARISON             298

11.9         COMPETITIVE SCENARIO             299

11.9.1      PRODUCT LAUNCHES AND APPROVALS               299

11.9.2      DEALS  300

11.9.3      EXPANSIONS     301

12            COMPANY PROFILES      302

12.1         KEY PLAYERS     302

12.1.1      ABBVIE INC.       302

12.1.1.1  Business overview 302

12.1.1.2  Products/Solutions offered 303

12.1.1.3  Recent developments           304

12.1.1.3.1                Product launches and approvals         304

12.1.1.4  MnM view              305

12.1.1.4.1                Key strengths        305

12.1.1.4.2                Strategic choices   305

12.1.1.4.3                Weaknesses and competitive threats 305

12.1.2      GALDERMA        306

12.1.2.1  Business overview 306

12.1.2.2  Products/Solutions offered 307

12.1.2.3  Recent developments           307

12.1.2.3.1                Product launches and approvals         307

12.1.2.3.2                Deals      308

12.1.2.3.3                Expansions             309

12.1.2.4  MnM view              309

12.1.2.4.1                Key strengths        309

12.1.2.4.2                Strategic choices   309

12.1.2.4.3                Weaknesses and competitive threats 309

12.1.3      JOHNSON & JOHNSON SERVICES, INC.   310

12.1.3.1  Business overview 310

12.1.3.2  Products/Solutions offered 311

12.1.3.3  Recent developments           312

12.1.3.3.1                Product launches and approvals         312

12.1.3.4  MnM view              313

12.1.3.4.1                Key strengths        313

12.1.3.4.2                Strategic choices   313

12.1.3.4.3                Weaknesses and competitive threats 313

12.1.4      BAUSCH HEALTH COMPANIES INC.         314

12.1.4.1  Business overview 314

12.1.4.2  Products/Solutions offered 315

12.1.4.3  Recent developments           316

12.1.4.3.1                Product launches and approvals         316

12.1.4.4  MnM view              316

12.1.4.4.1                Key strengths        316

12.1.4.4.2                Strategic choices   316

12.1.4.4.3                Weaknesses and competitive threats 316

12.1.5      CYNOSURE LUTRONIC  317

12.1.5.1  Business overview 317

12.1.5.2  Products/Solutions offered 317

12.1.5.3  Recent developments           319

12.1.5.3.1                Product launches and approvals         319

12.1.5.3.2                Deals      319

12.1.5.4  MnM view              320

12.1.5.4.1                Key strengths        320

12.1.5.4.2                Strategic choices   320

12.1.5.4.3                Weaknesses and competitive threats 320

12.1.6      CUTERA, INC.    321

12.1.6.1  Business overview 321

12.1.6.2  Products/Solutions offered 322

12.1.6.3  Recent developments           323

12.1.6.3.1                Product launches and approvals         323

12.1.6.3.2                Deals      324

12.1.7      MERZ PHARMA 325

12.1.7.1  Business overview 325

12.1.7.2  Products/Solutions offered 325

12.1.7.3  Recent developments           326

12.1.7.3.1                Expansions             327

12.1.8      LUMENIS BE LTD.            328

12.1.8.1  Business overview 328

12.1.8.2  Products/Solutions offered 328

12.1.8.3  Recent developments           329

12.1.8.3.1                Product launches and approvals         329

12.1.8.3.2                Deals      330

12.1.9      FOTONA              331

12.1.9.1  Business overview 331

12.1.9.2  Products/Solutions offered 331

12.1.9.3  Recent developments           332

12.1.9.3.1                Product launches and approvals         332

12.1.9.3.2                Expansions             333

12.1.10   AEROLASE CORP.             334

12.1.10.1                 Business overview 334

12.1.10.2                 Products/Solutions offered 334

12.1.10.3                 Recent developments           335

12.1.10.3.1             Product launches and approvals         335

12.1.11   SCITON                 336

12.1.11.1                 Business overview 336

12.1.11.2                 Products/Solutions offered 336

12.1.11.3                 Recent developments           337

12.1.11.3.1             Product launches and approvals         337

12.1.12   BOHUS BIOTECH AB      338

12.1.12.1                 Business overview 338

12.1.12.2                 Products/Solutions offered 338

12.1.13   RECOSMO           339

12.1.13.1                 Business overview 339

12.1.13.2                 Products/Solutions offered 339

12.1.14   SHARPLIGHT TECHNOLOGIES INC.         340

12.1.14.1                 Business overview 340

12.1.14.2                 Products/Solutions offered 340

12.1.14.3                 Recent developments           341

12.1.14.3.1             Product launches and approvals         341

12.1.15   CANDELA CORPORATION            342

12.1.15.1                 Business overview 342

12.1.15.2                 Products/Solutions offered 343

12.1.15.3                 Recent developments           344

12.1.15.3.1             Product launches and approvals         344

12.1.15.3.2             Deals      344

12.1.16   ALMA LASERS    345

12.1.16.1                 Business overview 345

12.1.16.2                 Products/Solutions offered 347

12.1.16.3                 Recent developments           348

12.1.16.3.1             Product launches and approvals         348

12.1.16.3.2             Deals      348

12.1.17   EL.EN. S.P.A.       349

12.1.17.1                 Business overview 349

12.1.17.2                 Products/Solutions offered 350

12.1.17.3                 Recent developments           352

12.1.17.3.1             Product launches and approvals         352

12.1.18   INMODE LTD.   353

12.1.18.1                 Business overview 353

12.1.18.2                 Products/Solutions offered 354

12.1.18.3                 Recent developments           356

12.1.18.3.1             Product launches and approvals         356

12.1.19   VENUS CONCEPT             357

12.1.19.1                 Business overview 357

12.1.19.2                 Products/Solutions offered 359

12.1.19.3                 Recent developments           360

12.1.19.3.1             Product launches and approvals         360

12.1.20   GC AESTHETICS               361

12.1.20.1                 Business overview 361

12.1.20.2                 Products/Solutions offered 361

12.1.20.3                 Recent developments           362

12.1.20.3.1             Product launches and approvals         362

12.1.20.3.2             Deals      362

12.2         OTHER COMPANIES       363

12.2.1      EVOLUS, INC.     363

12.2.2      ASCLEPION LASER TECHNOLOGIES        364

12.2.3      ASTANZA LASER               365

12.2.4      APYX MEDICAL 366

12.2.5      HUADONG MEDICINE CO., LTD.               366

12.2.6      MEDYTOX INC. 367

12.2.7      POLYTECH HEALTH & AESTHETICS GMBH          368

12.2.8      REVANCE AESTHETICS 369

12.2.9      PHOTOMEDEX 370

12.2.10   2L BIO CO., LTD.               371

13            APPENDIX           372

13.1         DISCUSSION GUIDE        372

13.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                376

13.3         CUSTOMIZATION OPTIONS        378

13.4         RELATED REPORTS         378

13.5         AUTHOR DETAILS           379

LIST OF TABLES

TABLE 1                MEDICAL AESTHETICS MARKET: INCLUSIONS AND EXCLUSIONS           34

TABLE 2                MEDICAL AESTHETICS MARKET: RISK ASSESSMENT     50

TABLE 3                MEDICAL AESTHETICS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS           60

TABLE 4                COMMERCIALLY AVAILABLE HOME-USE AESTHETIC DEVICES     64

TABLE 5                PLASTIC SURGEON FEES IN US, 2022 VS. 2023                 65

TABLE 6                AVERAGE SELLING PRICE TREND OF INJECTABLES, 2021–2023                68

TABLE 7                AVERAGE SELLING PRICE TREND OF ENERGY BASED-DEVICES,

BY REGION, 2021–2023 (USD THOUSAND)             71

TABLE 8                MEDICAL AESTHETICS MARKET: ROLE OF COMPANIES IN ECOSYSTEM       76

TABLE 9                MEDICAL AESTHETICS MARKET: LASER AND LIGHT-BASED TECHNOLOGIES 79

TABLE 10              APPLICATIONS OF RADIOFREQUENCY TECHNOLOGY  80

TABLE 11              MEDICAL AESTHETICS MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2023       83

TABLE 12              IMPORT SCENARIO FOR LASER AESTHETIC DEVICES (HS CODE 854370),

BY COUNTRY, 2019–2023 (USD THOUSAND)         84

TABLE 13              IMPORT SCENARIO FOR LASER (EXCLUDING DIODES) (HS CODE 901320),

BY COUNTRY, 2019–2023 (USD THOUSAND)         85

TABLE 14              EXPORT SCENARIO FOR LASER AESTHETIC DEVICES (HS CODE 854370),

BY COUNTRY, 2019–2023 (USD THOUSAND)         86

TABLE 15              EXPORT SCENARIO FOR LASER (EXCLUDING DIODES) (HS CODE 901320),

BY COUNTRY, 2019–2023 (USD THOUSAND)         87

TABLE 16              MEDICAL AESTHETICS MARKET: KEY CONFERENCES AND EVENTS, 2025–2026                 87

TABLE 17              CASE STUDY 1: COMMERCIAL PARTNERSHIPS FOR MEDICAL AESTHETIC

PRODUCT SALES              88

TABLE 18              CASE STUDY 2: DIVISION OF BUSINESS TO MEET CUSTOMER DEMANDS  88

TABLE 19              CASE STUDY 3: COLLABORATIONS WITH SMES FOR STREAMLINING

LASER-BASED DEVICES 88

TABLE 20              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  89

TABLE 21              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  89

TABLE 22              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  90

TABLE 23              REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  90

TABLE 24              US FDA: MEDICAL DEVICE CLASSIFICATION                 91

TABLE 25              REGULATORY APPROVALS FOR BODY CONTOURING DEVICES, BY COUNTRY  96

TABLE 26              MEDICAL AESTHETICS MARKET: PORTER’S FIVE FORCES ANALYSIS           97

TABLE 27              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY TYPE OF DEVICE  99

TABLE 28              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER                100

TABLE 29              MEDICAL AESTHETICS MARKET: UNMET NEEDS                 100

TABLE 30              MEDICAL AESTHETICS MARKET: COMPANIES IMPLEMENTING AI          102

TABLE 31              MEDICAL AESTHETICS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)            104

TABLE 32              MEDICAL AESTHETICS MARKET FOR FACIAL AESTHETIC PRODUCTS,

BY TYPE, 2022–2030 (USD MILLION)         105

TABLE 33              MEDICAL AESTHETICS MARKET FOR FACIAL AESTHETIC PRODUCTS,

BY REGION, 2022–2030 (USD MILLION)   106

TABLE 34              MEDICAL AESTHETICS MARKET FOR BOTULINUM TOXIN,

BY REGION, 2022–2030 (USD MILLION)   107

TABLE 35              MEDICAL AESTHETICS MARKET FOR DERMAL FILLERS,

BY TYPE, 2022–2030 (USD MILLION)         107

TABLE 36              MEDICAL AESTHETICS MARKET FOR DERMAL FILLERS,

BY REGION, 2022–2030 (USD MILLION)   108

TABLE 37              MEDICAL AESTHETICS MARKET FOR NATURAL DERMAL FILLERS,

BY REGION, 2022–2030 (USD MILLION)   109

TABLE 38              MEDICAL AESTHETICS MARKET FOR SYNTHETIC DERMAL FILLERS,

BY REGION, 2022–2030 (USD MILLION)   110

TABLE 39              CHEMICAL PEEL PROCEDURES PERFORMED WORLDWIDE, 2023           111

TABLE 40              MEDICAL AESTHETICS MARKET FOR CHEMICAL PEELS,

BY REGION, 2022–2030 (USD MILLION)   111

TABLE 41              MEDICAL AESTHETICS MARKET FOR MICRODERMABRASION,

BY REGION, 2022–2030 (USD MILLION)   112

TABLE 42              FACIAL BONE CONTOURING PROCEDURES PERFORMED WORLDWIDE, 2023                113

TABLE 43              MEDICAL AESTHETICS MARKET FOR BODY CONTOURING DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         114

TABLE 44              MEDICAL AESTHETICS MARKET FOR BODY CONTOURING DEVICES,

BY REGION, 2022–2030 (USD MILLION)   114

TABLE 45              NON-SURGICAL FAT REDUCTION PROCEDURES PERFORMED WORLDWIDE,

2019 VS. 2022 VS. 2023      115

TABLE 46              NON-SURGICAL FAT REDUCTION PROCEDURES PERFORMED WORLDWIDE, 2023                115

TABLE 47              MEDICAL AESTHETICS MARKET FOR NON-SURGICAL FAT REDUCTION DEVICES,

BY REGION, 2022–2030 (USD MILLION)   116

TABLE 48              CELLULITE REDUCTION PROCEDURES PERFORMED WORLDWIDE, 2023                116

TABLE 49              MEDICAL AESTHETICS MARKET FOR CELLULITE REDUCTION DEVICES,

BY REGION, 2022–2030 (USD MILLION)   117

TABLE 50              AGE DISTRIBUTION OF PATIENTS UNDERTAKING LIPOSUCTION PROCEDURES WORLDWIDE, 2023        118

TABLE 51              MEDICAL AESTHETICS MARKET FOR LIPOSUCTION DEVICES,

BY REGION, 2022–2030 (USD MILLION)   118

TABLE 52              MEDICAL AESTHETICS MARKET FOR COSMETIC IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         119

TABLE 53              MEDICAL AESTHETICS MARKET FOR COSMETIC IMPLANTS,

BY REGION, 2022–2030 (USD MILLION)   119

TABLE 54              MEDICAL AESTHETICS MARKET FOR BREAST IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         120

TABLE 55              MEDICAL AESTHETICS MARKET FOR BREAST IMPLANTS,

BY REGION, 2022–2030 (USD MILLION)   120

TABLE 56              PERCENTAGE OF PLASTIC SURGEONS PERFORMING SILICONE BREAST IMPLANTS WORLDWIDE, 2023                 121

TABLE 57              MEDICAL AESTHETICS MARKET FOR SILICONE BREAST IMPLANTS,

BY REGION, 2022–2030 (USD MILLION)   122

TABLE 58              PERCENTAGE OF PLASTIC SURGEONS PERFORMING SALINE BREAST IMPLANTS WORLDWIDE, 2023                 123

TABLE 59              MEDICAL AESTHETICS MARKET FOR SALINE BREAST IMPLANTS,

BY REGION, 2022–2030 (USD MILLION)   123

TABLE 60              MEDICAL AESTHETICS MARKET FOR FACIAL IMPLANTS,

BY REGION, 2022–2030 (USD MILLION)   124

TABLE 61              MEDICAL AESTHETICS MARKET FOR OTHER IMPLANTS,

BY REGION, 2022–2030 (USD MILLION)   125

TABLE 62              MEDICAL AESTHETICS MARKET FOR PHYSICIAN-DISPENSED COSMECEUTICALS

AND SKIN LIGHTENERS, BY REGION, 2022–2030 (USD MILLION)                 126

TABLE 63              MEDICAL AESTHETICS MARKET FOR SKIN AESTHETIC DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         127

TABLE 64              MEDICAL AESTHETICS MARKET FOR SKIN AESTHETIC DEVICES,

BY REGION, 2022–2030 (USD MILLION)   127

TABLE 65              MEDICAL AESTHETICS MARKET FOR LASER SKIN RESURFACING DEVICES,

BY REGION, 2022–2030 (USD MILLION)   128

TABLE 66              NON-SURGICAL SKIN TIGHTENING PROCEDURES PERFORMED WORLDWIDE, 2023  129

TABLE 67              MEDICAL AESTHETICS MARKET FOR NON-SURGICAL SKIN TIGHTENING DEVICES,

BY REGION, 2022–2030 (USD MILLION)   130

TABLE 68              MEDICAL AESTHETICS MARKET FOR MICRONEEDLING PRODUCTS,

BY REGION, 2022–2030 (USD MILLION)   131

TABLE 69              MEDICAL AESTHETICS MARKET FOR LIGHT THERAPY DEVICES,

BY REGION, 2022–2030 (USD MILLION)   132

TABLE 70              MEDICAL AESTHETICS MARKET FOR PHYSICIAN-DISPENSED EYELASH PRODUCTS,

BY REGION, 2022–2030 (USD MILLION)   133

TABLE 71              HAIR REMOVAL PROCEDURES PERFORMED WORLDWIDE, 2023           133

TABLE 72              MEDICAL AESTHETICS MARKET FOR HAIR REMOVAL DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         134

TABLE 73              MEDICAL AESTHETICS MARKET FOR HAIR REMOVAL DEVICES,

BY REGION, 2022–2030 (USD MILLION)   134

TABLE 74              MEDICAL AESTHETICS MARKET FOR LASER HAIR REMOVAL DEVICES,

BY REGION, 2022–2030 (USD MILLION)   135

TABLE 75              MEDICAL AESTHETICS MARKET FOR IPL HAIR REMOVAL DEVICES,

BY REGION, 2022–2030 (USD MILLION)   136

TABLE 76              MEDICAL AESTHETICS MARKET FOR TATTOO REMOVAL DEVICES,

BY REGION, 2022–2030 (USD MILLION)   137

TABLE 77              MEDICAL AESTHETICS MARKET FOR THREAD LIFT PRODUCTS,

BY REGION, 2022–2030 (USD MILLION)   138

TABLE 78              MEDICAL AESTHETICS MARKET FOR NAIL TREATMENT LASER DEVICES,

BY REGION, 2022–2030 (USD MILLION)   139

TABLE 79              MEDICAL AESTHETICS MARKET FOR HOME CARE DEVICES,

BY REGION, 2022–2030 (USD MILLION)   140

TABLE 80              MEDICAL AESTHETICS MARKET, BY TYPE OF DEVICE, 2022–2030 (USD MILLION)           142

TABLE 81              MEDICAL AESTHETICS DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)          142

TABLE 82              MEDICAL AESTHETICS MARKET FOR STANDALONE DEVICES,

BY REGION, 2022–2030 (USD MILLION)   143

TABLE 83              MEDICAL AESTHETICS MARKET FOR MULTIMODAL DEVICES,

BY REGION, 2022–2030 (USD MILLION)   144

TABLE 84              MEDICAL AESTHETICS MARKET FOR AT-HOME/SELF-USE DEVICES,

BY REGION, 2022–2030 (USD MILLION)   145

TABLE 85              MEDICAL AESTHETICS MARKET, BY PROCEDURE, 2022–2030 (USD MILLION)                147

TABLE 86              MEDICAL AESTHETICS MARKET FOR NON-SURGICAL PROCEDURES,

BY TYPE, 2022–2030 (USD MILLION)         147

TABLE 87              MEDICAL AESTHETICS MARKET FOR ANTI-AGING AND SKIN REJUVENATION,

BY REGION, 2022–2030 (USD MILLION)   148

TABLE 88              MEDICAL AESTHETICS MARKET FOR TATTOO REMOVAL,

BY REGION, 2022–2030 (USD MILLION)   149

TABLE 89              MEDICAL AESTHETICS MARKET FOR HAIR REMOVAL,

BY REGION, 2022–2030 (USD MILLION)   150

TABLE 90              MEDICAL AESTHETICS MARKET FOR LIPOSUCTION,

BY REGION, 2022–2030 (USD MILLION)   151

TABLE 91              MEDICAL AESTHETICS MARKET FOR OTHER NON-SURGICAL PROCEDURES,

BY REGION, 2022–2030 (USD MILLION)   152

TABLE 92              MEDICAL AESTHETICS MARKET FOR SURGICAL PROCEDURES,

BY TYPE, 2022–2030 (USD MILLION)         153

TABLE 93              MEDICAL AESTHETICS MARKET FOR BREAST IMPLANTS,

BY REGION, 2022–2030 (USD MILLION)   154

TABLE 94              MEDICAL AESTHETICS MARKET FOR FACELIFT & BODY LIFT PROCEDURES,

BY REGION, 2022–2030 (USD MILLION)   155

TABLE 95              MEDICAL AESTHETICS MARKET FOR OTHER SURGICAL PROCEDURES,

BY REGION, 2022–2030 (USD MILLION)   156

TABLE 96              MEDICAL AESTHETICS MARKET, BY END USER, 2022–2030 (USD MILLION)            158

TABLE 97              MEDICAL AESTHETICS MARKET FOR CLINICS, HOSPITALS, AND MEDICAL SPAS,

BY REGION, 2022–2030 (USD MILLION)   159

TABLE 98              MEDICAL AESTHETICS MARKET FOR BEAUTY CENTERS,

BY REGION, 2022–2030 (USD MILLION)   160

TABLE 99              MEDICAL AESTHETICS MARKET FOR HOME CARE SETTINGS,

BY REGION, 2022–2030 (USD MILLION)   161

TABLE 100            MEDICAL AESTHETICS MARKET, BY REGION, 2022–2030 (USD MILLION)            163

TABLE 101            NORTH AMERICA: MACROECONOMIC OUTLOOK           165

TABLE 102            NORTH AMERICA: MEDICAL AESTHETICS MARKET,

BY COUNTRY, 2022–2030 (USD MILLION)               165

TABLE 103            NORTH AMERICA: MEDICAL AESTHETICS MARKET,

BY PRODUCT, 2022–2030 (USD MILLION)               166

TABLE 104            NORTH AMERICA: MEDICAL AESTHETICS MARKET FOR FACIAL AESTHETIC PRODUCTS,

BY TYPE, 2022–2030 (USD MILLION)         167

TABLE 105            NORTH AMERICA: MEDICAL AESTHETICS MARKET FOR DERMAL FILLERS,

BY TYPE, 2022–2030 (USD MILLION)         167

TABLE 106            NORTH AMERICA: MEDICAL AESTHETICS MARKET FOR BODY CONTOURING DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         168

TABLE 107            NORTH AMERICA: MEDICAL AESTHETICS MARKET FOR COSMETIC IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         168

TABLE 108            NORTH AMERICA: MEDICAL AESTHETICS MARKET FOR BREAST IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         168

TABLE 109            NORTH AMERICA: MEDICAL AESTHETICS MARKET FOR SKIN AESTHETIC DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         169

TABLE 110            NORTH AMERICA: MEDICAL AESTHETICS MARKET FOR HAIR REMOVAL DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         169

TABLE 111            NORTH AMERICA: MEDICAL AESTHETICS MARKET,

BY TYPE OF DEVICE, 2022–2030 (USD MILLION) 170

TABLE 112            NORTH AMERICA: MEDICAL AESTHETICS MARKET, BY PROCEDURE,

2022–2030 (USD MILLION)            170

TABLE 113            NORTH AMERICA: MEDICAL AESTHETICS MARKET FOR NON-SURGICAL PROCEDURES,

BY TYPE, 2022–2030 (USD MILLION)         170

TABLE 114            NORTH AMERICA: MEDICAL AESTHETICS MARKET FOR SURGICAL PROCEDURES,

BY TYPE, 2022–2030 (USD MILLION)         171

TABLE 115            NORTH AMERICA: MEDICAL AESTHETICS MARKET, BY END USER,

2022–2030 (USD MILLION)            171

TABLE 116            US: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2023          172

TABLE 117            US: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)     173

TABLE 118            US: MEDICAL AESTHETICS MARKET FOR FACIAL AESTHETIC PRODUCTS,

BY TYPE, 2022–2030 (USD MILLION)         174

TABLE 119            US: MEDICAL AESTHETICS MARKET FOR BODY CONTOURING DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         174

TABLE 120            US: MEDICAL AESTHETICS MARKET FOR COSMETIC IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         175

TABLE 121            US: MEDICAL AESTHETICS MARKET FOR SKIN AESTHETIC DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         175

TABLE 122            US: MEDICAL AESTHETICS MARKET FOR HAIR REMOVAL DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         176

TABLE 123            CANADA: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)     177

TABLE 124            CANADA: MEDICAL AESTHETICS MARKET FOR FACIAL AESTHETIC PRODUCTS,

BY TYPE, 2022–2030 (USD MILLION)         177

TABLE 125            CANADA: MEDICAL AESTHETICS MARKET FOR BODY CONTOURING DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         178

TABLE 126            CANADA: MEDICAL AESTHETICS MARKET FOR COSMETIC IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         178

TABLE 127            CANADA: MEDICAL AESTHETICS MARKET FOR SKIN AESTHETIC DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         179

TABLE 128            CANADA: MEDICAL AESTHETICS MARKET FOR HAIR REMOVAL DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         179

TABLE 129            EUROPE: MEDICAL AESTHETIC PROCEDURES, BY COUNTRY, 2023           180

TABLE 130            EUROPE: MACROECONOMIC OUTLOOK                 181

TABLE 131            EUROPE: MEDICAL AESTHETICS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)     181

TABLE 132            EUROPE: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)     182

TABLE 133            EUROPE: MEDICAL AESTHETICS MARKET FOR FACIAL AESTHETIC PRODUCTS,

BY TYPE, 2022–2030 (USD MILLION)         182

TABLE 134            EUROPE: MEDICAL AESTHETICS MARKET FOR DERMAL FILLERS,

BY TYPE, 2022–2030 (USD MILLION)         183

TABLE 135            EUROPE: MEDICAL AESTHETICS MARKET FOR BODY CONTOURING DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         183

TABLE 136            EUROPE: MEDICAL AESTHETICS MARKET FOR COSMETIC IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         183

TABLE 137            EUROPE: MEDICAL AESTHETICS MARKET FOR BREAST IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         184

TABLE 138            EUROPE: MEDICAL AESTHETICS MARKET FOR SKIN AESTHETIC DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         184

TABLE 139            EUROPE: MEDICAL AESTHETICS MARKET FOR HAIR REMOVAL DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         184

TABLE 140            EUROPE: MEDICAL AESTHETICS MARKET, BY TYPE OF DEVICE,

2022–2030 (USD MILLION)            185

TABLE 141            EUROPE: MEDICAL AESTHETICS MARKET, BY PROCEDURE, 2022–2030 (USD MILLION)                185

TABLE 142            EUROPE: MEDICAL AESTHETICS MARKET FOR NON-SURGICAL PROCEDURES,

BY TYPE, 2022–2030 (USD MILLION)         185

TABLE 143            EUROPE: MEDICAL AESTHETICS MARKET FOR SURGICAL PROCEDURES,

BY TYPE, 2022–2030 (USD MILLION)         186

TABLE 144            EUROPE: MEDICAL AESTHETICS MARKET, BY END USER, 2022–2030 (USD MILLION)     186

TABLE 145            GERMANY: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2023 187

TABLE 146            GERMANY: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)     188

TABLE 147            GERMANY: MEDICAL AESTHETICS MARKET FOR FACIAL AESTHETIC PRODUCTS,

BY TYPE, 2022–2030 (USD MILLION)         188

TABLE 148            GERMANY: MEDICAL AESTHETICS MARKET FOR BODY CONTOURING DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         189

TABLE 149            GERMANY: MEDICAL AESTHETICS MARKET FOR COSMETIC IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         189

TABLE 150            GERMANY: MEDICAL AESTHETICS MARKET FOR SKIN AESTHETIC DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         190

TABLE 151            GERMANY: MEDICAL AESTHETICS MARKET FOR HAIR REMOVAL DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         190

TABLE 152            UK: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2023          191

TABLE 153            UK: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)     192

TABLE 154            UK: MEDICAL AESTHETICS MARKET FOR FACIAL AESTHETIC PRODUCTS,

BY TYPE, 2022–2030 (USD MILLION)         192

TABLE 155            UK: MEDICAL AESTHETICS MARKET FOR BODY CONTOURING DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         193

TABLE 156            UK: MEDICAL AESTHETICS MARKET FOR COSMETIC IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         193

TABLE 157            UK: MEDICAL AESTHETICS MARKET FOR SKIN AESTHETIC DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         194

TABLE 158            UK: MEDICAL AESTHETICS MARKET FOR HAIR REMOVAL DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         194

TABLE 159            FRANCE: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2023          195

TABLE 160            FRANCE: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)     196

TABLE 161            FRANCE: MEDICAL AESTHETICS MARKET FOR FACIAL AESTHETIC PRODUCTS,

BY TYPE, 2022–2030 (USD MILLION)         196

TABLE 162            FRANCE: MEDICAL AESTHETICS MARKET FOR BODY CONTOURING DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         197

TABLE 163            FRANCE: MEDICAL AESTHETICS MARKET FOR COSMETIC IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         197

TABLE 164            FRANCE: MEDICAL AESTHETICS MARKET FOR SKIN AESTHETIC DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         198

TABLE 165            FRANCE: MEDICAL AESTHETICS MARKET FOR HAIR REMOVAL DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         198

TABLE 166            ITALY: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2023          199

TABLE 167            ITALY: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)     200

TABLE 168            ITALY: MEDICAL AESTHETICS MARKET FOR FACIAL AESTHETIC PRODUCTS,

BY TYPE, 2022–2030 (USD MILLION)         200

TABLE 169            ITALY: MEDICAL AESTHETICS MARKET FOR BODY CONTOURING DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         201

TABLE 170            ITALY: MEDICAL AESTHETICS MARKET FOR COSMETIC IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         201

TABLE 171            ITALY: MEDICAL AESTHETICS MARKET FOR SKIN AESTHETIC DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         202

TABLE 172            ITALY: MEDICAL AESTHETICS MARKET FOR HAIR REMOVAL DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         202

TABLE 173            SPAIN: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2023          203

TABLE 174            SPAIN: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)     204

TABLE 175            SPAIN: MEDICAL AESTHETICS MARKET FOR FACIAL AESTHETIC PRODUCTS,

BY TYPE, 2022–2030 (USD MILLION)         204

TABLE 176            SPAIN: MEDICAL AESTHETICS MARKET FOR BODY CONTOURING DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         205

TABLE 177            SPAIN: MEDICAL AESTHETICS MARKET FOR COSMETIC IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         205

TABLE 178            SPAIN: MEDICAL AESTHETICS MARKET FOR SKIN AESTHETIC DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         206

TABLE 179            SPAIN: MEDICAL AESTHETICS MARKET FOR HAIR REMOVAL DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         206

TABLE 180            BELGIUM: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2023 207

TABLE 181            ROMANIA: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2023 207

TABLE 182            GREECE: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2023          208

TABLE 183            REST OF EUROPE: MEDICAL AESTHETICS MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            208

TABLE 184            REST OF EUROPE: MEDICAL AESTHETICS MARKET FOR FACIAL AESTHETIC PRODUCTS,

BY TYPE, 2022–2030 (USD MILLION)         209

TABLE 185            REST OF EUROPE: MEDICAL AESTHETICS MARKET FOR BODY CONTOURING DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         209

TABLE 186            REST OF EUROPE: MEDICAL AESTHETICS MARKET FOR COSMETIC IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         210

TABLE 187            REST OF EUROPE: MEDICAL AESTHETICS MARKET FOR SKIN AESTHETIC DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         210

TABLE 188            REST OF EUROPE: MEDICAL AESTHETICS MARKET FOR HAIR REMOVAL DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         211

TABLE 189            ASIA PACIFIC: MEDICAL AESTHETIC PROCEDURES, BY COUNTRY, 2023            211

TABLE 190            ASIA PACIFIC: MACROECONOMIC OUTLOOK                 213

TABLE 191            ASIA PACIFIC: MEDICAL AESTHETICS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)               214

TABLE 192            ASIA PACIFIC: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)               214

TABLE 193            ASIA PACIFIC: MEDICAL AESTHETICS MARKET FOR FACIAL AESTHETIC PRODUCTS,

BY TYPE, 2022–2030 (USD MILLION)         215

TABLE 194            ASIA PACIFIC: MEDICAL AESTHETICS MARKET FOR DERMAL FILLERS,

BY TYPE, 2022–2030 (USD MILLION)         215

TABLE 195            ASIA PACIFIC: MEDICAL AESTHETICS MARKET FOR BODY CONTOURING DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         215

TABLE 196            ASIA PACIFIC: MEDICAL AESTHETICS MARKET FOR COSMETIC IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         216

TABLE 197            ASIA PACIFIC: MEDICAL AESTHETICS MARKET FOR BREAST IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         216

TABLE 198            ASIA PACIFIC: MEDICAL AESTHETICS MARKET FOR SKIN AESTHETIC DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         217

TABLE 199            ASIA PACIFIC: MEDICAL AESTHETICS MARKET FOR HAIR REMOVAL DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         217

TABLE 200            ASIA PACIFIC: MEDICAL AESTHETICS MARKET, BY TYPE OF DEVICE,

2022–2030 (USD MILLION)            217

TABLE 201            ASIA PACIFIC: MEDICAL AESTHETICS MARKET, BY PROCEDURE,

2022–2030 (USD MILLION)            218

TABLE 202            ASIA PACIFIC: MEDICAL AESTHETICS MARKET FOR NON-SURGICAL PROCEDURES,

BY TYPE, 2022–2030 (USD MILLION)         218

TABLE 203            ASIA PACIFIC: MEDICAL AESTHETICS MARKET FOR SURGICAL PROCEDURES,

BY TYPE, 2022–2030 (USD MILLION)         219

TABLE 204            ASIA PACIFIC: MEDICAL AESTHETICS MARKET, BY END USER, 2022–2030 (USD MILLION)               219

TABLE 205            JAPAN: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2022          220

TABLE 206            JAPAN: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)     221

TABLE 207            JAPAN: MEDICAL AESTHETICS MARKET FOR FACIAL AESTHETIC PRODUCTS,

BY TYPE, 2022–2030 (USD MILLION)         221

TABLE 208            JAPAN: MEDICAL AESTHETICS MARKET FOR BODY CONTOURING DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         222

TABLE 209            JAPAN: MEDICAL AESTHETICS MARKET FOR COSMETIC IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         222

TABLE 210            JAPAN: MEDICAL AESTHETICS MARKET FOR SKIN AESTHETIC DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         223

TABLE 211            JAPAN: MEDICAL AESTHETICS MARKET FOR HAIR REMOVAL DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         223

TABLE 212            CHINA: ENERGY-BASED DEVICE PROCEDURES, 2023        224

TABLE 213            CHINA: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)     225

TABLE 214            CHINA: MEDICAL AESTHETICS MARKET FOR FACIAL AESTHETIC PRODUCTS,

BY TYPE, 2022–2030 (USD MILLION)         225

TABLE 215            CHINA: MEDICAL AESTHETICS MARKET FOR BODY CONTOURING DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         226

TABLE 216            CHINA: MEDICAL AESTHETICS MARKET FOR COSMETIC IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         226

TABLE 217            CHINA: MEDICAL AESTHETICS MARKET FOR SKIN AESTHETIC DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         227

TABLE 218            CHINA: MEDICAL AESTHETICS MARKET FOR HAIR REMOVAL DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         227

TABLE 219            INDIA: MOST COMMON SURGICAL PROCEDURES, 2023          228

TABLE 220            INDIA: BODY CONTOURING PROCEDURES CONDUCTED, 2020–2023                228

TABLE 221            INDIA: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)     229

TABLE 222            INDIA: MEDICAL AESTHETICS MARKET FOR FACIAL AESTHETIC PRODUCTS,

BY TYPE, 2022–2030 (USD MILLION)         229

TABLE 223            INDIA: MEDICAL AESTHETICS MARKET FOR BODY CONTOURING DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         230

TABLE 224            INDIA: MEDICAL AESTHETICS MARKET FOR COSMETIC IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         230

TABLE 225            INDIA: MEDICAL AESTHETICS MARKET FOR SKIN AESTHETIC DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         231

TABLE 226            INDIA: MEDICAL AESTHETICS MARKET FOR HAIR REMOVAL DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         231

TABLE 227            AUSTRALIA: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)               232

TABLE 228            AUSTRALIA: MEDICAL AESTHETICS MARKET FOR FACIAL AESTHETIC PRODUCTS,

BY TYPE, 2022–2030 (USD MILLION)         232

TABLE 229            AUSTRALIA: MEDICAL AESTHETICS MARKET FOR BODY CONTOURING DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         233

TABLE 230            AUSTRALIA: MEDICAL AESTHETICS MARKET FOR COSMETIC IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         233

TABLE 231            AUSTRALIA: MEDICAL AESTHETICS MARKET FOR SKIN AESTHETIC DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         234

TABLE 232            AUSTRALIA: MEDICAL AESTHETICS MARKET FOR HAIR REMOVAL DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         234

TABLE 233          SOUTH KOREA: MEDICAL AESTHETICS MARKET,

BY PRODUCT, 2022–2030 (USD MILLION)               235

TABLE 234            SOUTH KOREA: MEDICAL AESTHETICS MARKET FOR FACIAL AESTHETIC PRODUCTS,

BY TYPE, 2022–2030 (USD MILLION)         236

TABLE 235            SOUTH KOREA: MEDICAL AESTHETICS MARKET FOR BODY CONTOURING DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         236

TABLE 236            SOUTH KOREA: MEDICAL AESTHETICS MARKET FOR COSMETIC IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         237

TABLE 237            SOUTH KOREA: MEDICAL AESTHETICS MARKET FOR SKIN AESTHETIC DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         237

TABLE 238            SOUTH KOREA: MEDICAL AESTHETICS MARKET FOR HAIR REMOVAL DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         238

TABLE 239            THAILAND: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2023 239

TABLE 240            MALAYSIA: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2023 239

TABLE 241            BANGLADESH: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2023 240

TABLE 242            REST OF ASIA PACIFIC: MEDICAL AESTHETICS MARKET,

BY PRODUCT, 2022–2030 (USD MILLION)               240

TABLE 243            REST OF ASIA PACIFIC: MEDICAL AESTHETICS MARKET FOR FACIAL AESTHETIC PRODUCTS, BY TYPE, 2022–2030 (USD MILLION)       241

TABLE 244            REST OF ASIA PACIFIC: MEDICAL AESTHETICS MARKET FOR BODY CONTOURING

DEVICES, BY TYPE, 2022–2030 (USD MILLION)     241

TABLE 245            REST OF ASIA PACIFIC: MEDICAL AESTHETICS MARKET FOR COSMETIC IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         242

TABLE 246            REST OF ASIA PACIFIC: MEDICAL AESTHETICS MARKET FOR SKIN AESTHETIC DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         242

TABLE 247            REST OF ASIA PACIFIC: MEDICAL AESTHETICS MARKET FOR HAIR REMOVAL DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         242

TABLE 248            LATIN AMERICA: MEDICAL AESTHETIC PROCEDURES, BY COUNTRY, 2023            243

TABLE 249            LATIN AMERICA: MACROECONOMIC OUTLOOK                 244

TABLE 250            LATIN AMERICA: MEDICAL AESTHETICS MARKET, BY COUNTRY,

2022–2030 (USD MILLION)            244

TABLE 251            LATIN AMERICA: MEDICAL AESTHETICS MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            245

TABLE 252            LATIN AMERICA: MEDICAL AESTHETICS MARKET FOR FACIAL AESTHETIC PRODUCTS,

BY TYPE, 2022–2030 (USD MILLION)         245

TABLE 253            LATIN AMERICA: MEDICAL AESTHETICS MARKET FOR DERMAL FILLERS,

BY TYPE, 2022–2030 (USD MILLION)         246

TABLE 254            LATIN AMERICA: MEDICAL AESTHETICS MARKET FOR BODY CONTOURING DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         246

TABLE 255            LATIN AMERICA: MEDICAL AESTHETICS MARKET FOR COSMETIC IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         246

TABLE 256            LATIN AMERICA: MEDICAL AESTHETICS MARKET FOR BREAST IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         247

TABLE 257            LATIN AMERICA: MEDICAL AESTHETICS MARKET FOR SKIN AESTHETIC DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         247

TABLE 258            LATIN AMERICA: MEDICAL AESTHETICS MARKET FOR HAIR REMOVAL DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         247

TABLE 259            LATIN AMERICA: MEDICAL AESTHETICS MARKET, BY TYPE OF DEVICE,

2022–2030 (USD MILLION)            248

TABLE 260            LATIN AMERICA: MEDICAL AESTHETICS MARKET, BY PROCEDURE,

2022–2030 (USD MILLION)            248

TABLE 261            LATIN AMERICA: MEDICAL AESTHETICS MARKET FOR NON-SURGICAL PROCEDURES,

BY TYPE, 2022–2030 (USD MILLION)         248

TABLE 262            LATIN AMERICA: MEDICAL AESTHETICS MARKET FOR SURGICAL PROCEDURES,

BY TYPE, 2022–2030 (USD MILLION)         249

TABLE 263            LATIN AMERICA: MEDICAL AESTHETICS MARKET, BY END USER,

2022–2030 (USD MILLION)            249

TABLE 264            BRAZIL: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2023          250

TABLE 265            BRAZIL: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)     251

TABLE 266            BRAZIL: MEDICAL AESTHETICS MARKET FOR FACIAL AESTHETIC PRODUCTS,

BY TYPE, 2022–2030 (USD MILLION)         251

TABLE 267            BRAZIL: MEDICAL AESTHETICS MARKET FOR BODY CONTOURING DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         252

TABLE 268            BRAZIL: MEDICAL AESTHETICS MARKET FOR COSMETIC IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         252

TABLE 269            BRAZIL: MEDICAL AESTHETICS MARKET FOR SKIN AESTHETIC DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         253

TABLE 270            BRAZIL: MEDICAL AESTHETICS MARKET FOR HAIR REMOVAL DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         253

TABLE 271            MEXICO: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2023 254

TABLE 272            MEXICO: MEDICAL AESTHETICS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)     255

TABLE 273            MEXICO: MEDICAL AESTHETICS MARKET FOR FACIAL AESTHETIC PRODUCTS,

BY TYPE, 2022–2030 (USD MILLION)         255

TABLE 274            MEXICO: MEDICAL AESTHETICS MARKET FOR BODY CONTOURING DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         256

TABLE 275            MEXICO: MEDICAL AESTHETICS MARKET FOR COSMETIC IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         256

TABLE 276            MEXICO: MEDICAL AESTHETICS MARKET FOR SKIN AESTHETIC DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         257

TABLE 277            MEXICO: MEDICAL AESTHETICS MARKET FOR HAIR REMOVAL DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         257

TABLE 278            ARGENTINA: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2023 258

TABLE 279            COLOMBIA: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2023 259

TABLE 280            PERU: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2023          259

TABLE 281            VENEZUELA: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2023 260

TABLE 282            REST OF LATIN AMERICA: MEDICAL AESTHETICS MARKET,

BY PRODUCT, 2022–2030 (USD MILLION)               260

TABLE 283            REST OF LATIN AMERICA: MEDICAL AESTHETICS MARKET

FOR FACIAL AESTHETIC PRODUCTS, BY TYPE, 2022–2030 (USD MILLION)            261

TABLE 284            REST OF LATIN AMERICA: MEDICAL AESTHETICS MARKET

FOR BODY CONTOURING DEVICES, BY TYPE, 2022–2030 (USD MILLION)            261

TABLE 285            REST OF LATIN AMERICA: MEDICAL AESTHETICS MARKET

FOR COSMETIC IMPLANTS, BY TYPE, 2022–2030 (USD MILLION)                 262

TABLE 286            REST OF LATIN AMERICA: MEDICAL AESTHETICS MARKET

FOR SKIN AESTHETIC DEVICES, BY TYPE, 2022–2030 (USD MILLION)            262

TABLE 287            REST OF LATIN AMERICA: MEDICAL AESTHETICS MARKET

FOR HAIR REMOVAL DEVICES, BY TYPE, 2022–2030 (USD MILLION)            263

TABLE 288            MIDDLE EAST & AFRICA: MEDICAL AESTHETICS PROCEDURES, BY COUNTRY, 2023            263

TABLE 289            MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK           264

TABLE 290            MIDDLE EAST & AFRICA: MEDICAL AESTHETICS MARKET,

BY COUNTRY, 2022–2030 (USD MILLION)               264

TABLE 291            MIDDLE EAST & AFRICA: MEDICAL AESTHETICS MARKET,

BY PRODUCT, 2022–2030 (USD MILLION)               265

TABLE 292            MIDDLE EAST & AFRICA: MEDICAL AESTHETICS MARKET FOR FACIAL AESTHETIC PRODUCTS, BY TYPE, 2022–2030 (USD MILLION)       265

TABLE 293            MIDDLE EAST & AFRICA: MEDICAL AESTHETICS MARKET FOR DERMAL FILLERS,

BY TYPE, 2022–2030 (USD MILLION)         266

TABLE 294            MIDDLE EAST & AFRICA: MEDICAL AESTHETICS MARKET FOR BODY CONTOURING DEVICES, BY TYPE, 2022–2030 (USD MILLION)       266

TABLE 295            MIDDLE EAST & AFRICA: MEDICAL AESTHETICS MARKET FOR COSMETIC IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         266

TABLE 296            MIDDLE EAST & AFRICA: BREAST IMPLANTS MARKET, BY TYPE,

2022–2030 (USD MILLION)            267

TABLE 297            MIDDLE EAST & AFRICA: MEDICAL AESTHETICS MARKET FOR SKIN AESTHETIC DEVICES, BY TYPE, 2022–2030 (USD MILLION) 267

TABLE 298            MIDDLE EAST & AFRICA: MEDICAL AESTHETICS MARKET FOR HAIR REMOVAL DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         267

TABLE 299            MIDDLE EAST & AFRICA: MEDICAL AESTHETICS MARKET,

BY TYPE OF DEVICE, 2022–2030 (USD MILLION) 268

TABLE 300            MIDDLE EAST & AFRICA: MEDICAL AESTHETICS MARKET,

BY PROCEDURE, 2022–2030 (USD MILLION)          268

TABLE 301            MIDDLE EAST & AFRICA: MEDICAL AESTHETICS MARKET FOR NON-SURGICAL PROCEDURES, BY TYPE, 2022–2030 (USD MILLION)       269

TABLE 302            MIDDLE EAST & AFRICA: MEDICAL AESTHETICS MARKET FOR SURGICAL PROCEDURES, BY TYPE, 2022–2030 (USD MILLION) 269

TABLE 303            MIDDLE EAST & AFRICA: MEDICAL AESTHETICS MARKET,

BY END USER, 2022–2030 (USD MILLION)               270

TABLE 304            GCC COUNTRIES: MEDICAL AESTHETICS MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            271

TABLE 305            GCC COUNTRIES: MEDICAL AESTHETICS MARKET FOR FACIAL AESTHETIC PRODUCTS,

BY TYPE, 2022–2030 (USD MILLION)         271

TABLE 306            GCC COUNTRIES: MEDICAL AESTHETICS MARKET FOR BODY CONTOURING DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         272

TABLE 307            GCC COUNTRIES: MEDICAL AESTHETICS MARKET FOR COSMETIC IMPLANTS,

BY TYPE, 2022–2030 (USD MILLION)         272

TABLE 308            GCC COUNTRIES: MEDICAL AESTHETICS MARKET FOR SKIN AESTHETIC DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         273

TABLE 309            GCC COUNTRIES: MEDICAL AESTHETICS MARKET FOR HAIR REMOVAL DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         273

TABLE 310            IRAN: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2023          274

TABLE 311            SYRIA: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2023          274

TABLE 312            REST OF MIDDLE EAST & AFRICA: MEDICAL AESTHETICS MARKET,

BY PRODUCT, 2022–2030 (USD MILLION)               275

TABLE 313            REST OF MIDDLE EAST & AFRICA: MEDICAL AESTHETICS MARKET

FOR FACIAL AESTHETIC PRODUCTS, BY TYPE, 2022–2030 (USD MILLION)            275

TABLE 314            REST OF MIDDLE EAST & AFRICA: MEDICAL AESTHETICS MARKET

FOR BODY CONTOURING DEVICES, BY TYPE, 2022–2030 (USD MILLION)            276

TABLE 315            REST OF MIDDLE EAST & AFRICA: MEDICAL AESTHETICS MARKET

FOR COSMETIC IMPLANTS, BY TYPE, 2022–2030 (USD MILLION)                 276

TABLE 316            REST OF MIDDLE EAST & AFRICA: MEDICAL AESTHETICS MARKET

FOR SKIN AESTHETIC DEVICES, BY TYPE, 2022–2030 (USD MILLION)            277

TABLE 317            REST OF MIDDLE EAST & AFRICA: MEDICAL AESTHETICS MARKET

FOR HAIR REMOVAL DEVICES, BY TYPE, 2022–2030 (USD MILLION)            277

TABLE 318            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL AESTHETICS

MARKET, 2021–2024          279

TABLE 319            MEDICAL AESTHETICS MARKET: REGION FOOTPRINT       290

TABLE 320            MEDICAL AESTHETICS MARKET: PRODUCT FOOTPRINT       291

TABLE 321            MEDICAL AESTHETICS MARKET: TYPE OF DEVICE FOOTPRINT      292

TABLE 322            MEDICAL AESTHETICS MARKET: PROCEDURE FOOTPRINT       293

TABLE 323            MEDICAL AESTHETICS MARKET: END-USER FOOTPRINT       294

TABLE 324            MEDICAL AESTHETICS MARKET: LIST OF KEY STARTUPS/SMES              295

TABLE 325            MEDICAL AESTHETICS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES   296

TABLE 326            MEDICAL AESTHETICS MARKET: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–DECEMBER 2024 299

TABLE 327            MEDICAL AESTHETICS MARKET: DEALS, JANUARY 2021–DECEMBER 2024 300

TABLE 328            MEDICAL AESTHETICS MARKET: EXPANSIONS, JANUARY 2021–DECEMBER 2024 301

TABLE 329            ABBVIE INC.: COMPANY OVERVIEW        302

TABLE 330            ABBVIE INC.: PRODUCTS/SOLUTIONS OFFERED                 303

TABLE 331            ABBVIE INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–DECEMBER 2024      304

TABLE 332            GALDERMA: COMPANY OVERVIEW         306

TABLE 333            GALDERMA: PRODUCTS/SOLUTIONS OFFERED                 307

TABLE 334            GALDERMA: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–DECEMBER 2024      307

TABLE 335            GALDERMA: DEALS, JANUARY 2021–DECEMBER 2024        308

TABLE 336            GALDERMA: EXPANSIONS, JANUARY 2021–DECEMBER 2024                309

TABLE 337            JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW   310

TABLE 338            JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS/SOLUTIONS OFFERED          311

TABLE 339            JOHNSON & JOHNSON SERVICES, INC.: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–DECEMBER 2024 312

TABLE 340            BAUSCH HEALTH COMPANIES INC.: COMPANY OVERVIEW          314

TABLE 341            BAUSCH HEALTH COMPANIES INC.: PRODUCTS/SOLUTIONS OFFERED          315

TABLE 342            BAUSCH HEALTH COMPANIES INC.: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–DECEMBER 2024 316

TABLE 343            CYNOSURE LUTRONIC: COMPANY OVERVIEW                 317

TABLE 344            CYNOSURE LUTRONIC: PRODUCTS/SOLUTIONS OFFERED          317

TABLE 345            CYNOSURE LUTRONIC: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–DECEMBER 2024 319

TABLE 346            CYNOSURE LUTRONIC: DEALS, JANUARY 2021–DECEMBER 2024                319

TABLE 347            CUTERA, INC.: COMPANY OVERVIEW     321

TABLE 348            CUTERA, INC.: PRODUCTS/SOLUTIONS OFFERED             322

TABLE 349            CUTERA, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–DECEMBER 2024      323

TABLE 350            CUTERA, INC.: DEALS, JANUARY 2021–DECEMBER 2024                324

TABLE 351            MERZ PHARMA: COMPANY OVERVIEW  325

TABLE 352            MERZ PHARMA: PRODUCTS/SOLUTIONS OFFERED             325

TABLE 353            MERZ PHARMA: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–DECEMBER 2024 326

TABLE 354            MERZ PHARMA: EXPANSIONS, JANUARY 2021– DECEMBER 2024                327

TABLE 355            LUMENIS BE LTD.: COMPANY OVERVIEW                 328

TABLE 356            LUMENIS BE LTD.: PRODUCTS/SOLUTIONS OFFERED             328

TABLE 357            LUMENIS BE LTD.: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–DECEMBER 2024 329

TABLE 358            LUMENIS BE LTD.: DEALS, JANUARY 2021–DECEMBER 2024                330

TABLE 359            FOTONA: COMPANY OVERVIEW               331

TABLE 360            FOTONA: PRODUCTS/SOLUTIONS OFFERED                 331

TABLE 361            FOTONA: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–DECEMBER 2024      332

TABLE 362            FOTONA: EXPANSIONS, JANUARY 2021–DECEMBER 2024                333

TABLE 363            AEROLASE CORP.: COMPANY OVERVIEW                 334

TABLE 364            AEROLASE CORP.: PRODUCTS/SOLUTIONS OFFERED             334

TABLE 365            AEROLASE CORP.: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–DECEMBER 2024 335

TABLE 366            SCITON: COMPANY OVERVIEW 336

TABLE 367            SCITON: PRODUCTS/SOLUTIONS OFFERED                 336

TABLE 368            SCITON: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–DECEMBER 2024      337

TABLE 369            BOHUS BIOTECH AB: COMPANY OVERVIEW                 338

TABLE 370            BOHUS BIOTECH AB: PRODUCTS/SOLUTIONS OFFERED             338

TABLE 371            RECOSMO: COMPANY OVERVIEW            339

TABLE 372            RECOSMO: PRODUCTS/SOLUTIONS OFFERED                 339

TABLE 373            SHARPLIGHT TECHNOLOGIES INC.: COMPANY OVERVIEW          340

TABLE 374            SHARPLIGHT TECHNOLOGIES INC.: PRODUCTS/SOLUTIONS OFFERED          340

TABLE 375            SHARPLIGHT TECHNOLOGIES INC.: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–DECEMBER 2024 341

TABLE 376            CANDELA CORPORATION: COMPANY OVERVIEW          342

TABLE 377            CANDELA CORPORATION: PRODUCTS/SOLUTIONS OFFERED          343

TABLE 378            CANDELA CORPORATION: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–DECEMBER 2024 344

TABLE 379            CANDELA CORPORATION: DEALS, JANUARY 2021–DECEMBER 2024     344

TABLE 380            ALMA LASERS: COMPANY OVERVIEW     345

TABLE 381            ALMA LASERS: PRODUCTS/SOLUTIONS OFFERED             347

TABLE 382            ALMA LASERS: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–DECEMBER 2024      348

TABLE 383            ALMA LASERS: DEALS, JANUARY 2021–DECEMBER 2024                348

TABLE 384            EL.EN. S.P.A.: COMPANY OVERVIEW        349

TABLE 385            EL.EN. S.P.A.: PRODUCTS/SOLUTIONS OFFERED                 350

TABLE 386            EL.EN. S.P.A.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–DECEMBER 2024      352

TABLE 387            INMODE LTD.: COMPANY OVERVIEW    353

TABLE 388            INMODE LTD.: PRODUCTS/SOLUTIONS OFFERED             354

TABLE 389            INMODE LTD.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–DECEMBER 2024      356

TABLE 390            VENUS CONCEPT: COMPANY OVERVIEW                 357

TABLE 391            VENUS CONCEPT: PRODUCTS/SOLUTIONS OFFERED             359

TABLE 392            VENUS CONCEPT: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–DECEMBER 2024 360

TABLE 393            GC AESTHETICS: COMPANY OVERVIEW                 361

TABLE 394            GC AESTHETICS: PRODUCTS/SOLUTIONS OFFERED             361

TABLE 395            GC AESTHETICS: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–DECEMBER 2024 362

TABLE 396            GC AESTHETICS: DEALS, JANUARY 2021–DECEMBER 2024                362

TABLE 397            EVOLUS, INC.: COMPANY OVERVIEW     363

TABLE 398            ASCLEPION LASER TECHNOLOGIES: COMPANY OVERVIEW          364

TABLE 399            ASTANZA LASER: COMPANY OVERVIEW                 365

TABLE 400            APYX MEDICAL: COMPANY OVERVIEW 366

TABLE 401            HUADONG MEDICINE CO., LTD.: COMPANY OVERVIEW          366

TABLE 402            MEDYTOX INC.: COMPANY OVERVIEW  367

TABLE 403            POLYTECH HEALTH & AESTHETICS GMBH: COMPANY OVERVIEW   368

TABLE 404            REVANCE AESTHETICS: COMPANY OVERVIEW                 369

TABLE 405            PHOTOMEDEX: COMPANY OVERVIEW  370

TABLE 406            2L BIO CO., LTD.: COMPANY OVERVIEW                 371

LIST OF FIGURES

FIGURE 1              MEDICAL AESTHETICS MARKET SEGMENTATION AND REGIONAL SCOPE              33

FIGURE 2              MEDICAL AESTHETICS MARKET: YEARS CONSIDERED    35

FIGURE 3              MEDICAL AESTHETICS MARKET: RESEARCH DESIGN                37

FIGURE 4              BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS            42

FIGURE 5              BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION  43

FIGURE 6              RESEARCH METHODOLOGY: HYPOTHESIS BUILDING           44

FIGURE 7              MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH         45

FIGURE 8              MEDICAL AESTHETICS MARKET: END-USER-BASED MARKET SIZE ESTIMATION          46

FIGURE 9              MEDICAL AESTHETICS MARKET: GROWTH PROJECTIONS BASED ON REVENUE

IMPACT OF KEY MACRO INDICATORS   47

FIGURE 10            MEDICAL AESTHETICS MARKET: DATA TRIANGULATION METHODOLOGY         48

FIGURE 11            MEDICAL AESTHETICS MARKET, BY PRODUCT, 2024 VS. 2030 (USD MILLION)      51

FIGURE 12            MEDICAL AESTHETICS MARKET, BY PROCEDURE, 2024 VS. 2030 (USD MILLION)          52

FIGURE 13            MEDICAL AESTHETICS MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)      53

FIGURE 14            MEDICAL AESTHETICS MARKET, BY REGION, 2024–2030              54

FIGURE 15            GROWING ADOPTION OF MINIMALLY INVASIVE AND NON-INVASIVE AESTHETIC PROCEDURES TO DRIVE MARKET               55

FIGURE 16            FACIAL AESTHETIC PRODUCTS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD        56

FIGURE 17            CLINICS, HOSPITALS, AND MEDICAL SPAS DOMINATED MARKET IN 2023   57

FIGURE 18            ASIA PACIFIC TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD           58

FIGURE 19            MEDICAL AESTHETICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES          59

FIGURE 20            REVENUE SHIFT FOR PLAYERS IN MEDICAL AESTHETICS MARKET    66

FIGURE 21            AVERAGE SELLING PRICE OF ENERGY-BASED DEVICES, BY TYPE, 2023 (USD THOUSAND)          67

FIGURE 22            AVERAGE SELLING PRICE OF INJECTABLES, BY TYPE, 2021–2023 (USD)  68

FIGURE 23            AVERAGE SELLING PRICE OF ENERGY-BASED DEVICES,

BY KEY PLAYER, 2023 (USD THOUSAND)                69

FIGURE 24            AVERAGE SELLING PRICE TREND OF ENERGY-BASED DEVICES,

BY REGION, 2021–2023 (USD THOUSAND)             70

FIGURE 25            MEDICAL AESTHETICS MARKET: VALUE CHAIN ANALYSIS            72

FIGURE 26            MEDICAL AESTHETICS MARKET: SUPPLY CHAIN ANALYSIS            74

FIGURE 27            MEDICAL AESTHETICS MARKET: ECOSYSTEM ANALYSIS            75

FIGURE 28            INVESTMENT AND FUNDING SCENARIO, 2020–2024        77

FIGURE 29            NUMBER OF DEALS IN MEDICAL AESTHETICS MARKET, BY KEY PLAYER, 2020–2024        77

FIGURE 30            VALUE OF DEALS IN MEDICAL AESTHETICS MARKET, BY KEY PLAYER, 2020–2024 (USD)          78

FIGURE 31            MEDICAL AESTHETICS MARKET: PATENT ANALYSIS, 2013–2024       82

FIGURE 32            MEDICAL AESTHETICS MARKET: IMPORT SCENARIO FOR

LASER AESTHETIC DEVICES (HS CODE 854370), 2019–2023                 83

FIGURE 33            MEDICAL AESTHETICS MARKET: IMPORT SCENARIO FOR

LASER (EXCLUDING DIODES) (HS CODE 901320), 2019–2023                 84

FIGURE 34            MEDICAL AESTHETICS MARKET: EXPORT SCENARIO FOR

LASER AESTHETIC DEVICES (HS CODE 854370), 2019–2023                 85

FIGURE 35            MEDICAL AESTHETICS MARKET: EXPORT SCENARIO FOR

LASER (EXCLUDING DIODES) (HS CODE 901320), 2019–2023                 86

FIGURE 36            MEDICAL AESTHETICS MARKET: PORTER’S FIVE FORCES ANALYSIS           97

FIGURE 37            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY TYPE OF DEVICE  99

FIGURE 38            BUYING CRITERIA, BY END USER              100

FIGURE 39            AI USE CASES     101

FIGURE 40            NORTH AMERICA: MEDICAL AESTHETICS MARKET SNAPSHOT       164

FIGURE 41            ASIA PACIFIC: MEDICAL AESTHETICS MARKET SNAPSHOT          212

FIGURE 42            MEDICAL AESTHETICS MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2020–2023    280

FIGURE 43            ENERGY-BASED AESTHETIC DEVICES MARKET SHARE, 2023        281

FIGURE 44           FACIAL AESTHETIC PRODUCTS MARKET SHARE, 2023        282

FIGURE 45            COSMETIC IMPLANTS MARKET SHARE, 2023                 282

FIGURE 46            RANKING OF KEY PLAYERS IN MEDICAL AESTHETICS MARKET, 2023         283

FIGURE 47            ENERGY-BASED AESTHETIC DEVICES MARKET: COMPANY EVALUATION

MATRIX (KEY PLAYERS), 2023     285

FIGURE 48            FACIAL AESTHETIC PRODUCTS MARKET: COMPANY EVALUATION

MATRIX (KEY PLAYERS), 2023     286

FIGURE 49            COSMETIC IMPLANTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023         288

FIGURE 50            MEDICAL AESTHETICS MARKET: COMPANY FOOTPRINT       289

FIGURE 51            EV/EBITDA OF KEY VENDORS, 2024         297

FIGURE 52            5-YEAR STOCK BETA OF KEY VENDORS, 2024                 297

FIGURE 53            MEDICAL AESTHETICS MARKET: BRAND/PRODUCT COMPARISON             298

FIGURE 54            ABBVIE INC.: COMPANY SNAPSHOT (2023)                 303

FIGURE 55            GALDERMA: COMPANY SNAPSHOT (2023)                 306

FIGURE 56            JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2023)      311

FIGURE 57            BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT (2023)             315

FIGURE 58            CUTERA, INC.: COMPANY SNAPSHOT (2023)                 322

FIGURE 59            ALMA LASERS: COMPANY SNAPSHOT (2023)                 346

FIGURE 60            EL.EN. S.P.A.: COMPANY SNAPSHOT (2023)                 350

FIGURE 61            INMODE LTD.: COMPANY SNAPSHOT (2023)                 354

FIGURE 62            VENUS CONCEPT: COMPANY SNAPSHOT (2023)                 358

MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • ご注文後2営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

割引可能なレポートが多数ございます。価格・サンプルについてはお気軽にご相談ください。

最新調査レポート

• 沈降シリカ市場 – 2030年までの世界予測 2025-03-07
• スマートメーター市場 – 2030年までの世界予測 2025-03-07
• 産業用計測市場 – 2030年までの世界予測 2025-03-06
• 精密ろ過膜市場- 2029年までの世界予測 2025-03-06
• グリーンテクノロジーと持続可能性市場 – 2030年までの世界予測 2025-03-06

MarketsandMarkets  出版レポート一覧